Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACT2: Maintenance Erlotinib or Capecitabine in Metastatic Colorectal Cancer
NCT01229813Phase 3Completed
- Sponsor
- Skåne University Hospital
- Start
- Oct 2010
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of erlotinib in colorectal cancer (CRC), sponsored by Skåne University Hospital. Started Oct 2010; status: completed.
02
Drugs
erlotinib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01229813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01229813.